These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 7245542)

  • 1. The anticancer drug capsule with controlled-release for a long time and change of release rate.
    Yamada A; Sakurai Y; Nakamura K; Hanyu F; Yoshida M; Kaetsu I
    Trans Am Soc Artif Intern Organs; 1980; 26():514-7. PubMed ID: 7245542
    [No Abstract]   [Full Text] [Related]  

  • 2. [Continuous intra-arterial infusion of antineoplastic agents].
    Miura T; Ishida M
    Gan No Rinsho; 1972 Mar; ():Suppl:385-95. PubMed ID: 5064859
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on biodegradable microcapsules of anticancer drugs].
    Murata K; Nakamura K; Tsubakimoto M; Nakatsuka H; Minakuchi K; Onoyama Y; Kanamori R; Fukumori Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Jan; 51(1):94-6. PubMed ID: 2011488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-release depot for anticancer drugs: release of drugs covalently bonded to polymers.
    Yolles S
    J Parenter Drug Assoc; 1978; 32(4):188-91. PubMed ID: 249786
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of combination of folic acid and anticancer drugs on the growth of sarcoma 180 in mice.
    Indap MA; Gokhale SV
    J Postgrad Med; 1984 Jan; 30(1):23-6. PubMed ID: 6716305
    [No Abstract]   [Full Text] [Related]  

  • 6. [Silicone elastomers for the local administration of antineoplastic drugs].
    Mizutani Y
    Kokubyo Gakkai Zasshi; 1983 Mar; 50(1):154. PubMed ID: 6411838
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical application of microencapsulated antineoplastic agents].
    Kato T; Nemoto R
    Nihon Rinsho; 1982 Feb; 40(2):478-88. PubMed ID: 6806511
    [No Abstract]   [Full Text] [Related]  

  • 8. Antitumor activity of timed-release derivative of mitomycin C, agarose bead conjugate.
    Kojima T; Hashida M; Muranishi S; Sezaki H
    Chem Pharm Bull (Tokyo); 1978 Jun; 26(6):1818-24. PubMed ID: 699200
    [No Abstract]   [Full Text] [Related]  

  • 9. [Long-term controlled release of drugs].
    Siemińska L; Buntner B
    Wiad Lek; 2000; 53(11-12):670-6. PubMed ID: 11247411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled diffusional release of dispersed solute drugs from biodegradable implants of various geometries.
    Collins R; Paul Z; Reynolds DB; Short RF; Wasuwanich S
    Biomed Sci Instrum; 1997; 33():137-42. PubMed ID: 9731349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of drug release from capsules using high frequency energy transmission systems.
    Gröning R; Bensmann H; Müller RS
    Int J Pharm; 2008 Nov; 364(1):9-13. PubMed ID: 18682281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and evaluation of sustained release floating capsules of nicardipine hydrochloride.
    Moursy NM; Afifi NN; Ghorab DM; El-Saharty Y
    Pharmazie; 2003 Jan; 58(1):38-43. PubMed ID: 12622251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Local chemotherapy of malignant glioma: from syringe injections to nanotechnology].
    Petit S; Garcion E; Benoit JP; Menei P
    Rev Neurol (Paris); 2008; 164(6-7):547-53. PubMed ID: 18565353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of chemotherapy in the treatment of adenocarcinoma of the pancreas.
    Fennelly D; Kelsen DP
    Hepatogastroenterology; 1996; 43(8):356-62. PubMed ID: 8714228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of radiological therapy combined with anticancer drugs].
    Takahashi N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1967 Jul; 27(4):406-20. PubMed ID: 5237724
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel design of osmotic chitosan capsules characterized by asymmetric membrane structure for in situ formation of delivery orifice.
    Wang GM; Chen CH; Ho HO; Wang SS; Sheu MT
    Int J Pharm; 2006 Aug; 319(1-2):71-81. PubMed ID: 16701971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microparticulate drug delivery systems as an adjunct to cancer treatment.
    Kerr DJ
    Cancer Drug Deliv; 1987; 4(1):55-61. PubMed ID: 3300944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of anticancer agents in combination with hemoperfusion over charcoal.
    Yamagata J; Agishi T; Okumura T; Ota K; Umezu R
    Trans Am Soc Artif Intern Organs; 1981; 27():532-4. PubMed ID: 7331124
    [No Abstract]   [Full Text] [Related]  

  • 19. Intracavitary administration: pharmacokinetic advantages of macromolecular anticancer agents against peritoneal and pleural carcinomatoses.
    Kimura M; Konno T; Miyamoto Y; Kojima Y; Maeda H
    Anticancer Res; 1998; 18(4A):2547-50. PubMed ID: 9703908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer agents. 3. Synthesis and anticancer activity of some bis-thiosemicarbazones and thiosemicarbazides.
    Barry VC; Conalty ML; O'Callaghan CN; Twomey D
    Proc R Ir Acad B; 1967 Mar; 65(13):309-24. PubMed ID: 6045324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.